+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Prefilled Syringes Market by Type [Conventional (Disposable, Reusable), Safety], Material (Glass, Plastic), Design (Single-Chamber, Dual-Chamber, Customized), Application (Diabetes, Cancer, Arthritis, Anaphylaxis, Ophthalmology) and Region - Forecast to 2025

  • ID: 5146999
  • Report
  • September 2020
  • Region: Global
  • 145 Pages
  • Markets and Markets
The Global Prefilled Syringes Market is Expected to Reach USD 8.65 Billion by 2025 from USD 5.62 Billion in 2020, Growing at a CAGR of 9%

FEATURED COMPANIES

  • Baxter International Inc.
  • Dätwyler Holding Inc.
  • Gerresheimer AG
  • MedXL Inc.
  • Nipro Corporation
  • Schott AG
  • MORE

The global prefilled syringes market size is projected to reach USD 8.6 billion by 2025 from USD 5.6 billion in 2020, at a CAGR of 9%.



The growth in the prefilled syringes market is majorly driven by the rising demand for prefilled syringes is attributed to the growing prevalence of chronic diseases, technological advancements, rising adoption of self-injecting parenteral devices, and supportive government regulations (especially needlestick legislations). In addition, growing awareness on the benefits of prefilled syringes among patients and healthcare professionals, along with the growing number of biologics and biosimilars in the pharmaceuticals market, is supporting the growth of the prefilled syringes market. However, the adoption of prefilled syringes with integrated safety features has been low among end users, and the continuation of this trend during the forecast period will restrain the market growth.

The recent COVID-19 global pandemic has also impacted the prefilled syringes market. Routine care for chronic diseases is an ongoing challenge amidst the global COVID-19 pandemic due to the change in routine care to virtual communication. Diabetes, chronic obstructive pulmonary disease, and hypertension were the most impacted conditions due to a reduction in access to care. Furthermore, currently, most global healthcare resources are focused on coronavirus disease (COVID-19), and this resource reallocation is expected to disrupt the continuum of care for patients with chronic diseases.

Driver: Rising target disease population

Prefilled syringes are mainly used for the treatment of chronic conditions, such as heart diseases, diabetes, and autoimmune diseases, which require patients to self-administer medications. As a result, the increasing incidence and prevalence of chronic and lifestyle diseases across the globe is a major factor contributing to the growth of the prefilled syringes market. Moreover, there is a growing demand for self-injection devices, considering the convenience and safety associated with their use.

The following are some of the key statistics related to the growing incidence and prevalence of chronic diseases:

  • Globally, in 2019, approximately 436 million adults (prevalence 9.3%) were suffering from diabetes, and it is expected to rise to 700 million (prevalence 10.9%) by 2045. Moreover, more than 1.1 million children and adolescents are living with type 1 diabetes (Source: International Diabetes Federation)
  • In 2018, total number of cancer cases globally was recorded at 18 million. Most common cases being lung, breast, and colorectum cancer with incidence rate in double digits (Source: WHO)
  • According to the National Institute of Environmental Health Science, in 2017, 24 million people had a condition of autoimmune disease in the US. Moreover, 8 million people had auto-antibodies - blood molecules that indicate a person's chance of developing autoimmune disease

Restraint: Dearth of prefilled syringes with integrated safety features

Prefilled syringes provide greater patient safety by reducing the potential for inadvertent needle sticks and exposure to toxic products that can occur while drawing medication from vials. However, a significant number of needle stick injuries are associated with the use of bare prefilled syringes as compared to the ones that have integrated safety systems. As of 2019, ~500,000 injuries occur in the US annually, in which half of those (nearly 1,000 per day) occur in hospitals. Furthermore, as of 2019, ~1,000,000 injuries occurred annually in Europe. In such cases, the contaminated needle of prefilled syringes can lead to blood-borne infections, such as HIV and HCV.

Considering this, the limited market presence of prefilled syringes with integrated safety features, due to their expensive and challenging manufacturing procedure, is a major concern in the market. However, this trend is expected to change in the coming years, as the healthcare industry is laying greater emphasis on reducing the rate of needlestick injuries, which, in turn, is paving the way for the development of safety prefilled syringes.

Opportunity: Growing healthcare infrastructure across emerging markets

Emerging countries continue to suffer from insufficient healthcare funding, which adversely affects access to healthcare, quality, and, ultimately, the health status of citizens. According to the World Bank, approximately 400 million people lack access to essential healthcare services, mostly in Africa and South Asia. Furthermore, accelerating medical inflation, i.e., the cost of medical treatments and a higher prevalence of non-communicable lifestyle-related diseases such as cancer, diabetes, or cardiac syndromes, have resulted in funding gaps.

According to a report published by Geneva Association, in the last two decades, the share of total aggregate global expenditure on healthcare in GDP has increased from about 8% to almost 10%, or an estimated USD 8 trillion per annum, which is driven by the accelerating cost of medical treatment, expanding treatment options and increasing customer demands. Moreover, the Global Burden of Disease Health Financing Collaborator Network (2017) estimates that global spending on health will almost triple to USD 24 trillion by 2040 with upper-middle-income countries are estimated to show the fastest increase at an average of 5.3% per year. This growth could be attributed to continued growth in GDP and the rise of the middle class and government spending.

Challenge: Availability of cheaper alternatives

The purchase cost of prefilled syringes as compared to disposable syringes is significantly higher as a result of the high expenses involved in their manufacturing.

Traditionally, injectable were invasive and painful, which was the major reason for patients to prefer alternate routes of drug delivery, such as oral, topical, and nasal. Among the various routes of drug delivery, the oral route is the most preferred as it is easy to use, convenient, cost-effective, safe, and acceptable. Due to the above-mentioned factors, the adoption of alternative drug delivery technologies is increasing across the globe. For instance, the development of alternate, cost-effective delivery methods for insulin, such as Pfizer's Exubera (inhalable insulin) and Medtronic's Veo insulin pump (inhalable insulin), is limiting the use of injectable insulin.

Currently, insulin is mostly administered through injections, and thus, insulin injections form a significant market for injectable drug delivery technologies. However, the advent of inhalable insulin is expected to significantly impact the growth of this market as nasal drug delivery is pain-free and highly patient compliant. Also, the development of alternate delivery techniques for other disease indications, such as oral anemia treatment by GlaxoSmithKline and Bayer, is expected to adversely affect the growth of injectable technologies in the coming years.

By type, the safety prefilled syringes segment is expected to grow at the highest CAGR during the forecast period

The safety prefilled syringes segment is expected to witness the highest growth during the forecast period primarily due to the rising geriatric population globally and availability of biological therapies for patients with chronic conditions and outsourcing of low-risk medical procedures for chronic patients alleviates some of the pressure on hospitals.

Glass prefilled syringes is the largest material segment of the prefilled syringes market

The glass prefilled syringes segment accounted for the largest share of the prefilled syringes industry in 2019. The large share of this segment is attributed to the significant benefits offered, such as prevention of oxygen and water vapor from interacting with drug compounds, compatibility with different filling machines, and seamless integration into pharmaceutical companies’ PFS operations.

Single-chamber prefilled syringes accounted for the largest share of the prefilled syringes market, by design, in 2019

The single-chamber prefilled syringes segment accounted for the largest share of the prefilled syringes industry in 2019. Market growth can largely be attributed to the significant advantages with the use of single-chamber prefilled syringes over vials, such as optimized API use with less overfill, reduced material requirements, less drug waste in clinical trials, and simple storage & disposal.

Europe is the largest regional market for prefilled syringes

Europe is one of the major revenue-generating regions in the prefilled syringes market. Rising prevalence of chronic diseases, growth of the biologics and biosimilars market, technological advancements, geographical expansion by key manufacturers, aging population, and high adoption of self-injection devices are driving the demand for self-injectable prefilled syringes are the major factors driving the growth of the prefilled syringes market in Europe.prevalence of diabetes, and huge patient population.

COVID-19 Impact on the global prefilled syringes market

The prefilled syringes market is impacted due to the pandemic, resulting in impact of the pandemic on drug manufacturing and supply chain is expected to affect the market for the short term. Furthermore, HCPs have adapted to new ways of delivering care using telemedicine to reduce face-to-face contact, and adopting new ways of virtual healthcare and digital technologies is imperative to allow HCPs to continue routine appointments. Further, the use of apps can support self-management of chronic conditions, i.e., continuous glucose monitoring enables support with diabetes. Similarly, the contribution of community pharmacists to manage chronic conditions and promote medication adherence during this COVID-19 pandemic will be essential in easing the burden on already strained health systems.

Research Coverage

This report studies the prefilled syringes market based on the type, material, design, application, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

The major players operating in the prefilled syringes market are Becton, Dickinson and Company (US), Gerresheimer (Germany), SCHOTT AG (Germany), West Pharmaceutical Services, Inc. (US), Baxter International Inc (US), Ompi (Italy), Catalent, Inc. (US), Weigao Group (China), Vetter Pharma International GmbH (Germany), Nipro Corporation (Japan), Elcam Medical (Israel), YPSOMED (Switzerland), Oval Medical Technologies (UK), SHL Medical AG (Switzerland), Terumo (Japan).

Becton, Dickinson and Company (US) held the leadership position in the global prefilled syringes market with a share of 37.2% in 2019. The company’s dominant position in this market can be attributed to its broad product portfolio of prefilled syringes, strong geographical presence, and wide customer base. The company primarily focuses on the strategy of product launch.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1: 48%, Tier 2: 36%, and Tier 3: 16%
  • By Designation: C-level: 10%, D-level: 14%, and Others: 76%
  • By Region: North America: 40%, Europe: 32%, APAC: 20%, Latin America: 5%, and the Middle East & Africa: 3%

Key Benefits of Buying the Report

This report focuses on various levels of analysis - industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the prefilled syringes market, and high-growth regions and their drivers, restraints, opportunities, and challenges. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Baxter International Inc.
  • Dätwyler Holding Inc.
  • Gerresheimer AG
  • MedXL Inc.
  • Nipro Corporation
  • Schott AG
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Product Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency Used for the Study
1.5 Stakeholders

2 Research Methodology
2.1 Research Data
Figure 1 Research Design
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
Figure 2 Breakdown of Primaries: Prefilled Syringes and Supports Market
2.2 Market Estimation Methodology
Figure 3 Research Methodology: Hypothesis Building
2.2.1 End-user-Based Market Estimation
2.2.2 Revenue Mapping-Based Market Estimation
Figure 4 Market Size Estimation: Prefilled Syringes Market
2.2.3 Primary Research Validation
2.3 Data Triangulation
Figure 5 Data Triangulation Methodology
2.4 Research Assumptions
2.5 Research Limitations

3 Executive Summary
Figure 6 Global Prefilled Syringes Market, by Material, 2020 Vs. 2025 (In Terms of % Market Share)
Figure 7 Global Prefilled Syringes Market, by Type, 2016 Vs. 2021 (USD Billion)
Figure 8 Global Prefilled Syringes Market, by Design, 2020 Vs. 2025 (USD Billion)
Figure 9 Global Prefilled Syringes Market, by Application, 2020 Vs. 2025 (USD Billion)
Figure 10 Europe to Command the Largest Share of the Global Prefilled Syringes Market

4 Premium Insights
4.1 Prefilled Syringes Market Overview
Figure 11 Rising Prevalence of Autoimmune Disorders is Driving the Market Growth
4.2 Prefilled Syringes Market, by Type, 2020 Vs. 2025 (USD Million)
Figure 12 Reusable Prefilled Syringes Segment is Expected to Dominate the Market by 2025
4.3 Geographic Analysis: Prefilled Syringes Market, by Material
Figure 13 Asia-Pacific Segment to Possess High Growth Rate During the Forecast Period
4.4 Asia-Pacific: Prefilled Syringes Market, by Design and Country (2020)
Figure 14 Single-Chamber Prefilled Syringes Segment is Expected to Dominate the Asia-Pacific Market
4.5 Prefilled Syringes Market: Geographic Growth Opportunities
Figure 15 Asia-Pacific to Register the Highest CAGR During the Forecast Period

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 16 Prefilled Syringes Market: Drivers, Restraints, Opportunities, & Challenges
5.2.1 Drivers
5.2.1.1 Rising Target Disease Population
5.2.1.2 Rapid Growth in Generic Products
5.2.1.3 Rising Adoption of Self-Medication and Digitalization
5.2.1.4 Affordable Cost with Increased Efficiency of Prefilled Syringes
5.2.1.5 Technological Advancements
5.2.2 Restraints
5.2.2.1 Dearth of Prefilled Syringes with Integrated Safety Features
5.2.3 Opportunities
5.2.3.1 Growing Healthcare Infrastructure Across Emerging Markets
5.2.3.2 Surge of Biologics and Biosimilars in Biopharma Industry
5.2.3.3 Increasing Adoption of Wearable Drug Delivery Technologies
5.2.4 Challenges
5.2.4.1 Availability of Cheaper Alternatives
5.2.4.2 Challenges Associated with Manufacturing of Prefilled Syringes
5.2.5 Regulatory Scenario
5.2.6 COVID-19 Impact

6 Prefilled Syringes Market, by Type
6.1 Introduction
Table 1 Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 2 Prefilled Syringes Market, by Type, 2019 (Million Units)
6.2 Conventional Prefilled Syringes
Table 3 Global Conventional Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 4 Conventional Prefilled Syringes Market, by Type, 2019 (Million Units)
Table 5 Global Conventional Prefilled Syringes Market Size, by Region, 2018-2025 (USD Million)
Table 6 Global Conventional Prefilled Syringes Market, by Region, 2019 (Million Units)
Table 7 Global Conventional Prefilled Syringes Market Size, by Material, 2018-2025 (USD Million)
Table 8 Global Conventional Prefilled Syringes Market Size, by Design, 2018-2025 (USD Million)
Table 9 Global Conventional Prefilled Syringes Market Size, by Application, 2018-2025 (USD Million)
6.2.1 Disposable Prefilled Syringes
Table 10 Global Disposable Prefilled Syringes Market Size, by Region, 2018-2025 (USD Million)
Table 11 Global Disposable Prefilled Syringes Market, by Region, 2019 (Million Units)
Table 12 Global Disposable Prefilled Syringes Market Size, by Material, 2018-2025 (USD Million)
Table 13 Global Disposable Prefilled Syringes Market Size, by Design, 2018-2025 (USD Million)
Table 14 Global Disposable Prefilled Syringes Market Size, by Application, 2018-2025 (USD Million)
6.2.2 Reusable Prefilled Syringes
Table 15 Global Reusable Prefilled Syringes Market Size, by Region, 2018-2025 (USD Million)
Table 16 Global Reusable Prefilled Syringes Market, by Region, 2019 (Million Units)
Table 17 Global Reusable Prefilled Syringes Market Size, by Material, 2018-2025 (USD Million)
Table 18 Global Reusable Prefilled Syringes Market Size, by Design, 2018-2025 (USD Million)
Table 19 Global Reusable Prefilled Syringes Market Size, by Application, 2018-2025 (USD Million)
6.3 Safety Prefilled Syringes
Table 20 Global Safety Prefilled Syringes Market Size, by Region, 2018-2025 (USD Million)
Table 21 Global Safety Prefilled Syringes Market, by Region, 2019 (Million Units)
Table 22 Global Safety Prefilled Syringes Market Size, by Material, 2018-2025 (USD Million)
Table 23 Global Safety Prefilled Syringes Market Size, by Design, 2018-2025 (USD Million)
Table 24 Global Safety Prefilled Syringes Market Size, by Application, 2018-2025 (USD Million)

7 Prefilled Syringes Market, by Material
7.1 Introduction
Table 25 Global Prefilled Syringes Market Size, by Material, 2018-2025 (USD Million)
7.2 Glass Prefilled Syringes
Table 26 Global Glass Prefilled Syringes Market Size, by Region, 2018-2025 (USD Million)
7.3 Plastic Prefilled Syringes
Table 27 Global Plastic Prefilled Syringes Market Size, by Region, 2018-2025 (USD Million)

8 Prefilled Syringes Market, by Design
8.1 Introduction
Table 28 Prefilled Syringes Market Size, by Design, 2018-2025 (USD Million)
8.2 Single-Chamber Prefilled Syringes
Table 29 Single-Chamber Prefilled Syringes Market Size, by Region, 2018-2025 (USD Million)
8.3 Dual-Chamber Prefilled Syringes
Table 30 Global Dual-Chamber Prefilled Syringes Market Size, by Region, 2018-2025 (USD Million)
8.4 Customized Prefilled Syringes
Table 31 Global Customized Prefilled Syringes Market Size, by Region, 2018-2025 (USD Million)

9 Prefilled Syringes Market, by Application
9.1 Introduction
Table 32 Prefilled Syringes Market Size, by Application, 2018-2025 (USD Million)
9.2 Diabetes
Table 33 Global Prefilled Syringes Market for Diabetes, by Region, 2018-2025 (USD Million)
9.3 Rheumatoid Arthritis
Table 34 Global Prefilled Syringes Market for Rheumatoid Arthritis, by Region, 2018-2025 (USD Million)
9.4 Anaphylaxis
Table 35 Global Prefilled Syringes Market for Anaphylaxis, by Region, 2018-2025 (USD Million)
9.5 Cancer
Table 36 Global Prefilled Syringes Market for Cancer, by Region, 2018-2025 (USD Million)
9.6 Thrombosis
Table 37 Global Prefilled Syringes Market for Thrombosis, by Region, 2018-2025 (USD Million)
9.7 Ophthalmology
Table 38 Global Prefilled Syringes Market for Ophthalmology, by Region, 2018-2025 (USD Million)
9.8 Others
Table 39 Global Prefilled Syringes Market for Others, by Region, 2018-2025 (USD Million)

10 Prefilled Syringes Market, by Region
10.1 Introduction
Table 40 Global Prefilled Syringes Market Size, by Region, 2018-2025 (USD Million)
Table 41 Prefilled Syringes Market, by Region, 2019 (Million Units)
10.2 North America
Table 42 North America Prefilled Syringes Market Size, by Country, 2018-2025 (USD Million)
Table 43 North America Prefilled Syringes Market Size, by Material, 2018-2025 (USD Million)
Table 44 North America Prefilled Syringes Market Size, by Design, 2018-2025 (USD Million)
Table 45 North America Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 46 North America Conventional Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 47 North America Prefilled Syringes Market Size, by Application, 2018-2025 (USD Million)
10.2.1 US
10.2.1.1 US to Dominate the Market in North America
Table 48 US Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 49 US Conventional Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
10.2.2 Canada
10.2.2.1 Rising Geriatric Population to Drive Market Growth
Table 50 Canada Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 51 Canada Conventional Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
10.3 Europe
Table 52 Europe Prefilled Syringes Market Size, by Country, 2018-2025 (USD Million)
Table 53 Europe Prefilled Syringes Market Size, by Material, 2018-2025 (USD Million)
Table 54 Europe Prefilled Syringes Market Size, by Design, 2018-2025 (USD Million)
Table 55 Europe Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 56 Europe Conventional Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 57 Europe Prefilled Syringes Market Size, by Application, 2018-2025 (USD Million)
10.3.1 Germany
10.3.1.1 Germany to Dominate the Market in Europe
Table 58 Germany Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 59 Germany Conventional Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
10.3.2 UK
10.3.2.1 Growing Number of CVD and Diabetes Patients to Drive Market Growth
Table 60 UK Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 61 UK Conventional Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
10.3.3 France
10.3.3.1 Increasing Needlestick Injuries and High Adoption of Self-Administration to Drive Market Growth
Table 62 France Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 63 France Conventional Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
10.3.4 Italy
10.3.4.1 Growing Focus of Pharmaceutical and Medical Device Companies on Development of Prefilled Syringes to Aid Market Growth
Table 64 Italy Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 65 Italy Conventional Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
10.3.5 Spain
10.3.5.1 High Cancer and Diabetes Prevalence to Drive the Market
Table 66 Spain Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 67 Spain Conventional Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
10.3.6 Rest of Europe (RoE)
Table 68 RoE Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 69 RoE Conventional Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
10.4 Asia-Pacific
Table 70 Asia-Pacific Prefilled Syringes Market Size, by Country, 2018-2025 (USD Million)
Table 71 Asia-Pacific Prefilled Syringes Market Size, by Material, 2018-2025 (USD Million)
Table 72 Asia-Pacific Prefilled Syringes Market Size, by Design, 2018-2025 (USD Million)
Table 73 Asia-Pacific Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 74 Asia-Pacific Conventional Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 75 Asia-Pacific Prefilled Syringes Market Size, by Application, 2018-2025 (USD Million)
10.4.1 China
10.4.1.1 Growing R&D Activities and Localized Manufacturing are Expected to Drive Market Growth
Table 76 China Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 77 China Conventional Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
10.4.2 India
10.4.2.1 Growing Cancer Rate and Heart Diseases to Drive the Market
Table 78 India Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 79 India Conventional Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
10.4.3 Japan
10.4.3.1 Growing Demand for Self-Injection Technologies to Drive the Market
Table 80 Japan Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 81 Japan Conventional Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
10.4.4 South Korea
10.4.4.1 Rising R&D Activities Focused on Prefilled Syringes are Driving the Market
Table 82 South Korea Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 83 South Korea Conventional Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
10.4.5 Australia
10.4.5.1 Growing Healthcare Expenditure and Infrastructure to Aid Market Growth
Table 84 Australia Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 85 Australia Conventional Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
10.4.6 Rest of Asia-Pacific
Table 86 RoAPAC Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 87 RoAPAC Conventional Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
10.5 Latin America
Table 88 Latin America Prefilled Syringes Market Size, by Country, 2018-2025 (USD Million)
Table 89 Latin America Prefilled Syringes Market Size, by Material, 2018-2025 (USD Million)
Table 90 Latin America Prefilled Syringes Market Size, by Design, 2018-2025 (USD Million)
Table 91 Latin America Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 92 Latin America Conventional Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 93 Latin America Prefilled Syringes Market Size, by Application, 2018-2025 (USD Million)
10.5.1 Brazil
10.5.1.1 Brazil Accounted for the Largest Share of the Latin American Market
Table 94 Brazil Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 95 Brazil Conventional Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
10.5.2 Mexico
10.5.2.1 Growing Drug Delivery Market to Support Growth
Table 96 Mexico Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 97 Mexico Conventional Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
10.5.3 Rest of Latin America (RoLA)
Table 98 RoLA Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 99 RoLA Conventional Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
10.6 Middle East & Africa
Table 100 Middle East & Africa Prefilled Syringes Market Size, by Material, 2018-2025 (USD Million)
Table 101 Middle East & Africa Prefilled Syringes Market Size, by Design, 2018-2025 (USD Million)
Table 102 Middle East & Africa Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 103 Middle East & Africa Conventional Prefilled Syringes Market Size, by Type, 2018-2025 (USD Million)
Table 104 Middle East & Africa Prefilled Syringes Market Size, by Application, 2018-2025 (USD Million)

11 Competitive Landscape
11.1 Overview
Figure 17 Key Developments in the Prefilled Syringes Market from 2017 to 2020
11.2 Global Market Share Analysis (2019)
Figure 18 Becton, Dickinson & Company Held the Leading Position in the Prefilled Syringes Market in 2019
11.3 Competitive Scenario (2017-2020)
Figure 19 Major Companies Focuses on Market Expansions to Maintain Its High Market Share and to Build Its Competitive Advantage
11.3.1 Key Product Launches (2017-20120)
11.3.2 Key Expansions (2017-2020)
11.3.3 Key Mergers and Acquisitions (2017-2020)
11.3.4 Key Partnerships, Agreements, and Collaborations (2017-2020)

12 Company Evaluation Matrix and Company Profiles
12.1 Company Evaluation Matrix Definitions and Methodology
12.1.1 Vendor Inclusion Criteria
12.1.1.1 Star
12.1.1.2 Emerging Leader
12.1.1.3 Pervasive
12.1.1.4 Emerging Companies
Figure 20 Prefilled Syringes Market (Global) Competitive Leadership Mapping, 2019
12.2 Company Profiles
12.2.1 Gerresheimer AG
Figure 21 Company Snapshot: Gerresheimer AG
12.2.2 Schott AG
Figure 22 Company Snapshot: Schott AG
12.2.3 Becton, Dickinson & Company
Figure 23 Company Snapshot: Becton, Dickinson & Company
12.2.4 West Pharmaceutical Services, Inc.
Figure 24 Company Snapshot: West Pharmaceutical Services, Inc.
12.2.5 Vetter Pharma International GmbH
12.2.6 Weigao Group
Figure 25 Company Snapshot: Weigao Group
12.2.7 Ompi (A Stevanato Group Company)
12.2.8 Catalent, Inc.
Figure 26 Company Snapshot: Catalent, Inc.
12.2.9 Nipro Corporation
Figure 27 Company Snapshot: Nipro Corporation
12.2.10 Baxter International Inc.
Figure 28 Company Snapshot: Baxter International, Inc.
12.2.11 Elcam Medical
12.2.12 Ypsomed
Figure 29 Company Snapshot: Ypsomed
12.2.13 Oval Medical Technologies Ltd.
12.2.14 SHL Medical AG
12.2.15 Terumo Corporation
Figure 30 Company Snapshot: Terumo Corporation
12.2.16 Other Companies
12.2.16.1 Haselmeier
12.2.16.2 Micsafe
12.2.16.3 Dätwyler Holding Inc.
12.2.16.4 Owen Mumford Ltd.
12.2.16.5 MedXL Inc.

13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: The Subscription Portal
13.3 Available Customizations

Note: Product cover images may vary from those shown
  •  Baxter International Inc.
  • Becton, Dickinson & Company
  • Catalent, Inc.
  • Dätwyler Holding Inc.
  • Elcam Medical
  • Gerresheimer AG
  • Haselmeier
  • MedXL Inc.
  • Micsafe
  • Nipro Corporation
  • Ompi (A Stevanato Group Company)
  • Oval Medical Technologies Ltd.
  • Owen Mumford Ltd.
  • Schott AG
  • SHL Medical AG
  • Terumo Corporation
  • Vetter Pharma International GmbH
  • Weigao Group
  • West Pharmaceutical Services, Inc.
  • Ypsomed
Note: Product cover images may vary from those shown
Adroll
adroll